Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Part 2: On the Horizon: Oral Tofacitinib

In this edition of Derm Insider, host Neal Bhatia, MD tackles the evolving systemic treatment landscape for psoriasis with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD. In Part II, they weigh the potential of the oral investigational agent tofacitinib.

More Videos in this Series